NCT01645709View on ClinicalTrials.gov

Safety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the Knee

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2013

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Verapamil

DRUG

Placebo

Sponsors

Collaborators (1)

Premier Research
All Listed Sponsors
collaborator

Premier Research

OTHER

lead

Calosyn Pharma, Inc.

INDUSTRY

NCT01645709 - Safety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter